Tim Wilsdon is speaking during the conference in a session titled “Improving Patient Access to Innovative Cancer Therapies: The Role of Managed Entry Agreements.”
For more information on this event, click here.
Root causes to solutions: A policy proposal to address generic drug shortages
In the United States, drug shortages have become a persistent public health issue, negatively impacting patient care and outcomes. In the last decade, the...